Rong Fan

Harold Hodgkinson Professor of Biomedical Engineering

Yale University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (32)

Cellular senescence is a hallmark of aging and a driver of functional decline across tissues, yet its heterogeneity and context dependence have limited systematic study. The Common Fund’s Cellular Senescence Network (SenNet) Program addresses this challenge by generating multimodal, multi-tissue datasets that profile senescent cells across the human lifespan and complementary mouse models. The SenNet Data Portal ( https://data.sennetconsortium.org ) serves as the public gateway to these resources, providing open access to harmonized single-cell, spatial, imaging, transcriptomic, and proteomic data; senescence biomarker catalogs; and standardized protocols that can be used to comprehensively identify and characterize senescent cells in mouse and human tissue. As of January 2026, the portal hosts 1,753 publicly available human and mouse datasets across 15 organs using 6 general assay types. Experts from 13 Tissue Mapping Centers (TMCs) and 12 Technology Development and Application (TDAs) components contribute tissue data, analyze data, identify senescent biomarkers, and agree on panels for cross-tissue antibody harmonization. They also register human tissue data into the Human Reference Atlas (HRA) and develop user interfaces for the multiscale and multimodal exploration of this data. Built on a scalable hybrid cloud microservices architecture by the Consortium Organization and Data Coordinating Center (CODCC), the Portal enables data submission, management, integrated analysis, spatial context mapping, and cross-species senescence mapping critical for aging research. This paper presents user needs, the Portal’s architecture, data processing workflows, and senescence-focused analytical tools. The paper also presents usage scenarios illustrating applications in biomarker discovery, quality benchmarking, hypothesis generation, spatial analysis, cost-efficient profiling, and cell distance distribution analysis. Current limitations and planned extensions—including expanded spatial-omics releases and improved tools for senotype characterization—are discussed. SenNet protocols, code, and user interfaces are freely available on https://docs.sennetconsortium.org/apis .

Year:

2026

Spatial omics data acquisition is constrained by an inherent trilemma: balancing experimental cost, spatial resolution, and profiling scope (in terms of both plexity and field of view). Currently, spot-based technologies coupled with histological images represent one of the most scalable solutions, yet they lack single-cell precision and are often limited in field of view for omics. Here, we introduce SuperFocus, an AI-powered framework that predicts omics features with high fidelity for individual cells across whole-slide images from spotlevel omics data acquired on the same or adjacent slides. It sub-stantially relaxes the trilemma by achieving single-cell resolution and whole-slide field of view without increasing experimental cost or sacrificing plexity. SuperFocus implements a novel constrained cascading imputation scheme to minimize hallucination and outputs two per-feature quality-control scores that flag potentially unreliable predictions for each feature. When predicting for cells outside the profiled field of view, SuperFocus additionally provides a prediction-credibility score for each cell that prevents overconfidence when relevant histological patterns are undersampled or absent from the training data. We validate the fidelity of SuperFocus by benchmarking against multiple ground-truth single-cell and subcellular resolution spatial datasets across different platforms, demonstrating highly concordant cell-level feature recovery. We evaluate SuperFocus on both spatial transcriptomics and spatial epigenomics modalities and observe consistent performance over diverse platforms, tissues, and conditions. We demonstrate its utility by resolving the MALT lymphoma microenvironment at single-cell resolution using spot-level Patho-DBiT data, and by performing single-cell resolution motif analysis of the human hippocampus using spot-level spatial ATAC-seq. Overall, SuperFocus provides an effective in silico solution to the spatial omics trilemma, empowering single-cell-resolved spatial analysis from standard spot-level inputs and histological images.

Year:

2025

​Spatially resolved in vivo CRISPR screening integrates gene editing with spatial transcriptomics to examine how genetic perturbations alter gene expression within native tissue environments. However, current methods are limited to small perturbation panels and the detection of a narrow subset of protein-coding RNAs. We present Perturb-DBiT, a distinct and versatile approach for the simultaneous co-sequencing of spatial total RNA whole-transcriptome and single-guide RNAs (sgRNAs), base-by-base, on the same tissue section. This method enables unbiased discovery of how genetic perturbations influence RNA regulation, cellular dynamics, and tissue architecture in situ. Applying Perturb-DBiT to a human cancer metastatic colonization model, we mapped large panels of sgRNAs across tumor colonies in consecutive tissue sections alongside their corresponding total RNA transcriptomes. This revealed novel insights into how perturbations affect long non-coding RNA (lncRNA) co-variation, microRNA–mRNA interactions, and global and distinct tRNA alterations in amino acid metabolism linked to tumor migration and growth. By integrating transcriptional pseudotime trajectories, we further uncovered the impact of perturbations on clonal dynamics and cooperation. In an immune-competent syngeneic mouse model, Perturb-DBiT enabled investigation of genetic perturbations within the tumor immune microenvironment, revealing distinct and synergistic effects on immune infiltration and suppression. Perturb-DBiT provides a spatially resolved comprehensive view of how genetic knockouts influence diverse molecular and cellular responses including small and large RNA regulation, tumor proliferation, migration, metastasis, and immune interactions, offering a panoramic perspective on perturbation responses in complex tissues.

Year:

2025

Spatially mapping the transcriptome and proteome in the same tissue section can significantly advance our understanding of heterogeneous cellular processes and connect cell type to function. Here, we present Deterministic Barcoding in Tissue sequencing plus (DBiTplus), an integrative multi-modality spatial omics approach that combines sequencing-based spatial transcriptomics and image-based spatial protein profiling on the same tissue section to enable both single-cell resolution cell typing and genome-scale interrogation of biological pathways. DBiTplus begins with in situ reverse transcription for cDNA synthesis, microfluidic delivery of DNA oligos for spatial barcoding, retrieval of barcoded cDNA using RNaseH, an enzyme that selectively degrades RNA in an RNA-DNA hybrid, preserving the intact tissue section for high-plex protein imaging with CODEX. We developed computational pipelines to register data from two distinct modalities. Performing both DBiT-seq and CODEX on the same tissue slide enables accurate cell typing in each spatial transcriptome spot and subsequently image-guided decomposition to generate single-cell resolved spatial transcriptome atlases. DBiTplus was applied to mouse embryos with limited protein markers but still demonstrated excellent integration for single-cell transcriptome decomposition, to normal human lymph nodes with high-plex protein profiling to yield a single-cell spatial transcriptome map, and to human lymphoma FFPE tissue to explore the mechanisms of lymphomagenesis and progression. DBiTplusCODEX is a unified workflow including integrative experimental procedure and computational innovation for spatially resolved single-cell atlasing and exploration of biological pathways cell-by-cell at genome-scale.

Year:

2024

With the advent of spatial multi-omics, we can mosaic integrate diverse datasets with partially overlapping modalities to construct consensus multi-modal spatial atlases of the source tissue. SpaMosaic is a spatial multi-omics mosaic integration tool that employs contrastive learning and graph neural networks to construct a modality-agnostic and batch-corrected latent space suited for analyses like spatial domain identification and imputing missing omes. Using simulated and experimentally acquired datasets, we benchmarked SpaMosaic against single-cell multi-omics mosaic integration methods. The experimental data encompassed RNA and protein abundance, chromatin accessibility or histone modifications, acquired from brain, embryo, tonsil, and lymph node tissues. SpaMosaic achieved superior performance over existing methods in identifying known spatial domains with enhanced resolution and clarity while reducing noise and batch effects. It also ranked top for modality alignment, enabling seamless diagonal integration without the need for image registration. After integration, SpaMosaic can also impute missing modalities. With a mosaic set of mouse brain data with RNA and different epigenomic modalities, we integrated and imputed the missing omics. There we found the imputed gene activity scores of activating and silencing histone marks show the correct correlation with RNA. Moreover, we uncovered more region-specific genes and pathways showing the correct transcriptome-epigenome correlations in the imputed histone modification than in the measured chromatin accessibility modalities. Lastly, SpaMosaic’s imputation also allows the inference of relationships between different modalities without requiring co-profiling from the same section.

Year:

2024

Perturb-seq enabled the profiling of transcriptional effects of genetic perturbations in single cells but lacks the ability to examine the impact on tissue environments. We present Perturb-DBiT for simultaneous co- sequencing of spatial transcriptome and guide RNAs (gRNAs) on the same tissue section for in vivo CRISPR screen with genome-scale gRNA libraries, offering a comprehensive understanding of how genetic modifications affect cellular behavior and tissue architecture. This platform supports a variety of delivery vectors, gRNA library sizes, and tissue preparations, along with two distinct gRNA capture methods, making it adaptable to a wide range of experimental setups. In applying Perturb-DBiT, we conducted un-biased knockouts of tens of genes or at genome-wide scale across three cancer models. We mapped all gRNAs in individual colonies and corresponding transcriptomes in a human cancer metastatic colonization model, revealing clonal dynamics and cooperation. We also examined the effect of genetic perturbation on the tumor immune microenvironment in an immune-competent syngeneic model, uncovering differential and synergistic perturbations in promoting immune infiltration or suppression in tumors. Perturb-DBiT allows for simultaneously evaluating the impact of each knockout on tumor initiation, development, metastasis, histopathology, and immune landscape. Ultimately, it not only broadens the scope of genetic inquiry, but also lays the groundwork for developing targeted therapeutic strategies.

Year:

2024

Effective cancer immunotherapies restore anti-tumor immunity by rewiring cell-cell communication. Treatment-induced changes in communication can be inferred from single-cell RNA-sequencing (scRNA-seq) data, but current methods do not effectively manage heterogeneity within cell types. Here we developed a computational approach to efficiently analyze scRNA-seq-derived, single-cell-resolved cell-cell interactomes, which we applied to determine how agonistic CD40 (CD40ag) alters immune cell crosstalk alone, across tumor models, and in combination with immune checkpoint blockade (ICB). Our analyses suggested that CD40ag improves responses to ICB by targeting both immuno-stimulatory and immunosuppressive macrophage subsets communicating with T cells, and we experimentally validated a spatial basis for these subsets with immunofluorescence and spatial transcriptomics. Moreover, treatment with CD40ag and ICB established coordinated myeloid-T cell interaction hubs that are critical for reestablishing antitumor immunity. Our work advances the biological significance of hypotheses generated from scRNA-seq-derived cell-cell interactomes and supports the clinical translation of myeloid-targeted therapies for ICB-resistant tumors.

Year:

2024

The ability to spatially map multiple layers of the omics information over different time points allows for exploring the mechanisms driving brain development, differentiation, arealization, and alterations in disease. Herein we developed and applied spatial tri-omic sequencing technologies, DBiT ARP-seq (spatial ATAC–RNA–Protein-seq) and DBiT CTRP-seq (spatial CUT&Tag–RNA–Protein-seq) together with multiplexed immunofluorescence imaging (CODEX) to map spatial dynamic remodeling in brain development and neuroinflammation. A spatiotemporal tri-omic atlas of the mouse brain was obtained at different stages from postnatal day P0 to P21, and compared to the regions of interest in the human developing brains. Specifically, in the cortical area, we discovered temporal persistence and spatial spreading of chromatin accessibility for the layer-defining transcription factors. In corpus callosum, we observed dynamic chromatin priming of myelin genes across the subregions. Together, it suggests a role for layer specific projection neurons to coordinate axonogenesis and myelination. We further mapped the brain of a lysolecithin (LPC) neuroinflammation mouse model and observed common molecular programs in development and neuroinflammation. Microglia, exhibiting both conserved and distinct programs for inflammation and resolution, are transiently activated not only at the core of the LPC lesion, but also at distal locations presumably through neuronal circuitry. Thus, this work unveiled common and differential mechanisms in brain development and neuroinflammation, resulting in a valuable data resource to investigate brain development, function and disease.

Year:

2024

The ability to spatially map multiple layers of the omics information over different time points allows for exploring the mechanisms driving brain development, differentiation, arealization, and alterations in disease. Herein we developed and applied spatial tri-omic sequencing technologies, DBiT ARP-seq (spatial ATAC–RNA–Protein-seq) and DBiT CTRP-seq (spatial CUT&Tag– RNA–Protein-seq) together with multiplexed immunofluorescence imaging (CODEX) to map spatial dynamic remodeling in brain development and neuroinflammation. A spatiotemporal tri-omic atlas of the mouse brain was obtained at different stages from postnatal day P0 to P21, and compared to the regions of interest in the human developing brains. Specifically, in the cortical area, we discovered temporal persistence and spatial spreading of chromatin accessibility for the layer-defining transcription factors. In corpus callosum, we observed dynamic chromatin priming of myelin genes across the subregions. Together, it suggests a role for layer specific projection neurons to coordinate axonogenesis and myelination. We further mapped the brain of a lysolecithin (LPC) neuroinflammation mouse model and observed common molecular programs in development and neuroinflammation. Microglia, exhibiting both conserved and distinct programs for inflammation and resolution, are transiently activated not only at the core of the LPC lesion, but also at distal locations presumably through neuronal circuitry. Thus, this work unveiled common and differential mechanisms in brain development and neuroinflammation, resulting in a valuable data resource to investigate brain development, function and disease.

Year:

2024

Changes in chromatin accessibility in HCC827 and PC9 cells upon ASCL1 expression. Global changes in chromatin accessibility in mutant EGFR lung cancer cell lines following ASCL1 overexpression and osimertinib treatment.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (42)

Shondra Pruett-Miller

Associate Member

St. Jude Children's Research Hospital

UNITED STATES
View details

Zhiliang Bai

Yale University

UNITED STATES
View details

Qin Yan

Anthony N. Brady Professor of Pathology

Yale University

UNITED STATES
View details

Nils Gehlenborg

Associate Professor

Harvard Medical School

UNITED STATES
View details

Patty J. Lee

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Mark Gerstein

Yale University

UNITED STATES
View details

Jonathan Silverstein

Professor

University of Pittsburgh

UNITED STATES
View details

Per Uhlén

Professor

Karolinska Institutet

SWEDEN
View details

Fabian Theis

Director of the Institute of Computational Biology and Professor

Technical University of Munich

GERMANY
View details

Susan Kaech

Director & Professor

Salk Institute for Biological Studies

UNITED STATES
View details

Kathryn Miller-Jensen

Associate Professor

Yale University

UNITED STATES
View details

Katy Börner

Indiana State University

UNITED STATES
View details

Nancy Zhang

Professor

University of Pennsylvania

UNITED STATES
View details

Carlos Talavera-López

Junior Professor

Julius-Maximilians-Universität Würzburg Medizinische Fakultät

GERMANY
View details

Arnold R. Kriegstein

UCSF Medical Center

UNITED STATES
View details

Yang Liu

Assistant Professor

Yale University

UNITED STATES
View details

Harriet Kluger

Yale University School of Medicine

UNITED STATES
View details

SIDI CHEN

Yale University

UNITED STATES
View details

Marcus Bosenberg

Professor

Yale University

UNITED STATES
View details

Jungmin Choi

Associate Professor

Korea University

SOUTH KOREA
View details

Zongming Ma

Faculty

Yale University

UNITED STATES
View details

Gonçalo Castelo-Branco

Professor of Glial Cell Biology

Karolinska Institutet

SWEDEN
View details

Daifeng Wang

Associate Professor

University of Wisconsin-Madison

UNITED STATES
View details

Haikuo Li

PI

Shanghai Jiao Tong University

CHINA
View details

Li Wang

Assistant Professor

Stanford University

UNITED STATES
View details

Bo Tao

professor

Zhejiang University

CHINA
View details

William Damsky

Associate Professor of Dermatology

Yale University

UNITED STATES
View details

Eneritz Agirre

Karolinska Institutet

SWEDEN
View details

Hongyu Zhao

Professor

Yale University

UNITED STATES
View details

jinmiao chen

Associate Professor

Duke-NUS Medical School

SINGAPORE
View details

Giulia Biancon

Start-Up Principal Investigator

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

ITALY
View details

Omer Bayraktar

Group Leader

Wellcome Sanger Institute

UNITED KINGDOM
View details

So-Jin Kim

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Samuel Peters

University of Minnesota

UNITED STATES
View details

Guoping Cai

Professor

Yale University

UNITED STATES
View details

Shigeaki Kanatani

Staff scientist

Karolinska Institutet

SWEDEN
View details

Yang Xiao

Assistant Professor

University of Michigan

UNITED STATES
View details

Robert Homer

Yale University School of Medicine

UNITED STATES
View details

Lijun Wang

Assistant Professor

Zhejiang University

CHINA
View details

Zenta Walther

Associate Professor

Yale University School of Medicine

UNITED STATES
View details

Min Li

Central South University

CHINA
View details

Andreas Bueckle

Research Lead

Indiana University

UNITED STATES
View details